drugset / Trial / NCT06106893
A Clinical Study of CD19 Universal CAR-γδT Cells in Active Systemic Lupus Erythematosus
Phase 1/2
Recruiting
15 enrolled
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Guangzhou Bio-gene Technology Co., Ltd · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of the study is to explore the safety and efficacy of CD19 Universal CAR-γδT cells in active severe systemic lupus erythematosus.
Timeline
- Start
- 2024-01-12
- Primary completion
- 2025-12
- Completion
- 2027-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | CD19 Universal CAR-γδ T Cells | Cell therapy | — | Intravenous |